Logo image of CWD

CALIBERCOS INC-CL A (CWD) Stock Fundamental Analysis

USA - NASDAQ:CWD - US13000T6047 - Common Stock

3.64 USD
-0.34 (-8.54%)
Last: 10/16/2025, 8:00:01 PM
3.4319 USD
-0.21 (-5.72%)
Pre-Market: 10/17/2025, 9:06:49 AM
Fundamental Rating

1

CWD gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 237 industry peers in the Capital Markets industry. Both the profitability and financial health of CWD have multiple concerns. CWD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CWD has reported negative net income.
CWD had a negative operating cash flow in the past year.
In the past 5 years CWD reported 4 times negative net income.
In the past 5 years CWD reported 4 times negative operating cash flow.
CWD Yearly Net Income VS EBIT VS OCF VS FCFCWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

With a Return On Assets value of -35.26%, CWD is not doing good in the industry: 89.87% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -35.26%
ROE N/A
ROIC N/A
ROA(3y)-7.38%
ROA(5y)-4.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWD Yearly ROA, ROE, ROICCWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CWD Yearly Profit, Operating, Gross MarginsCWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

0

2. Health

2.1 Basic Checks

CWD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CWD has been increased compared to 5 years ago.
The debt/assets ratio for CWD is higher compared to a year ago.
CWD Yearly Shares OutstandingCWD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CWD Yearly Total Debt VS Total AssetsCWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -1.57, we must say that CWD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.57, CWD is doing worse than 88.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.57
ROIC/WACCN/A
WACCN/A
CWD Yearly LT Debt VS Equity VS FCFCWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.56 indicates that CWD may have some problems paying its short term obligations.
With a Current ratio value of 0.56, CWD is not doing good in the industry: 75.53% of the companies in the same industry are doing better.
CWD has a Quick Ratio of 0.56. This is a bad value and indicates that CWD is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CWD (0.56) is worse than 75.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
CWD Yearly Current Assets VS Current LiabilitesCWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

CWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.64%, which is quite impressive.
CWD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -55.17%.
Measured over the past years, CWD shows a decrease in Revenue. The Revenue has been decreasing by -8.07% on average per year.
EPS 1Y (TTM)36.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.68%
Revenue 1Y (TTM)-55.17%
Revenue growth 3Y-3.01%
Revenue growth 5Y-8.07%
Sales Q2Q%-37.98%

3.2 Future

The Earnings Per Share is expected to grow by 42.41% on average over the next years. This is a very strong growth
CWD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.01% yearly.
EPS Next Y48.55%
EPS Next 2Y42.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-32.19%
Revenue Next 2Y3.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CWD Yearly Revenue VS EstimatesCWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
CWD Yearly EPS VS EstimatesCWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 -5 -10 -15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CWD. In the last year negative earnings were reported.
CWD is valuated cheaply with a Price/Forward Earnings ratio of 7.21.
86.08% of the companies in the same industry are more expensive than CWD, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CWD to the average of the S&P500 Index (22.85), we can say CWD is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.21
CWD Price Earnings VS Forward Price EarningsCWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWD Per share dataCWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CWD's earnings are expected to grow with 42.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.41%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CWD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALIBERCOS INC-CL A

NASDAQ:CWD (10/16/2025, 8:00:01 PM)

Premarket: 3.4319 -0.21 (-5.72%)

3.64

-0.34 (-8.54%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners0.18%
Inst Owner Change0%
Ins Owners6.18%
Ins Owner Change0%
Market Cap16.45M
Analysts80
Price Target38.76 (964.84%)
Short Float %9.69%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.11%
Min Revenue beat(2)-15.34%
Max Revenue beat(2)3.12%
Revenue beat(4)3
Avg Revenue beat(4)24.25%
Min Revenue beat(4)-15.34%
Max Revenue beat(4)80.63%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11500%
EPS NY rev (1m)-140.68%
EPS NY rev (3m)-140.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-34.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-27.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.21
P/S 0.51
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-18
EYN/A
EPS(NY)0.51
Fwd EY13.87%
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS7.15
BVpS-4.39
TBVpS-4.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.38%
ROA(5y)-4.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z -1.57
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.68%
EPS Next Y48.55%
EPS Next 2Y42.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-55.17%
Revenue growth 3Y-3.01%
Revenue growth 5Y-8.07%
Sales Q2Q%-37.98%
Revenue Next Year-32.19%
Revenue Next 2Y3.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y66.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.25%
FCF growth 3YN/A
FCF growth 5Y-35.8%
OCF growth 1Y81.25%
OCF growth 3YN/A
OCF growth 5Y-35.8%